Glucose transporter-1 expression in the thyroid gland: Clinicopathological significance for papillary carcinoma

Oncology Reports

Volumn 14, Issue 6, 2005, Pages 1499-1504

  Yasuda, Masanori ^a   Ogane, Naoki ^b   Hayashi, Hiroyuki ^b   Kameda, Yoichi ^b   Miyagi, Yohei ^b   Iida, Tetsuji ^a   Mori, Yusuke ^c   Tsukinoki, Keiichi ^c   Minematsu, Takeo ^a   Osamura, R Yoshiyuki ^a  

^a TOKAI UNIVERSITY   (Japan)

^b KANAGAWA CANCER CENTER   (Japan)

^c KANAGAWA DENTAL COLLEGE   (Japan)

Author keywords

Glucose transporter 1; Glut 1 mRNA; Immunohistochemistry; Papillary carcinoma; Thyroid gland

Indexed keywords

GLUCOSE TRANSPORTER 1; MESSENGER RNA;

ADENOCARCINOMA; ADENOMA; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METABOLISM; METASTASIS; PAPILLARY CARCINOMA; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID GLAND; THYROID TUMOR; WESTERN BLOTTING;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; BLOTTING, WESTERN; CARCINOMA, PAPILLARY; GENE EXPRESSION; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROID GLAND; THYROID NEOPLASMS;

EID: 33644689966     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.14.6.1499     Document Type: Article

References (29)

1. Joost HG and Thorens B: The extended GLUT-1 family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members. Mol Membr Biol 18: 247-256, 2001.
2. Medina RA and Owen GI: Glucose transporters: expression, regulation and cancer. Biol Res 35: 9-26, 2002. (Pubitemid 34661867)
3. Kayano T, Burant CF, Fukumoto H, Gould GW, Fan Y-S, Eddy RL, Byers MG, Shows TB, Seino S and Bell GI: Human facilitative glucose transporters: Isolation, functional characterization and gene localization of cDNAs encoding an isoform (GLUT-5) expressed in small intestine, kidney, muscle, and adipose tissue and an unusual glucose transporter pseudogene-like sequence (GLUT-6). J Biol Chem 265: 13276-13282, 1990.
4. Pessin JE and Bell GI: Mammalian facilitative glucose transporter family: structure and molecular regulation. Annu Rev Physiol 54: 911-930, 1992.
5. Froehner SC, Davies A, Baldwin SA and Lienhard GE: The blood-nerve barrier is rich in glucose transporter. J Neurocytol 17: 173-178, 1998.
6. Pardridge W, Boado R and Farrell C: Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. J Biol Chem 265: 18035-18040, 1990.
7. Takata K, Kasahara T, Kasahara M, Ezaki O and Hirano H: Localization of erythrocyte/HepG2-type glucose transporter (GLUT-1) in human placental villi. Cell Tissue Res 267: 407-412, 1992.
8. Doria-Medina CL, Lund DD, Pasley A, Sandra A and Sivitz WI: Immunolocalization of GLUT-1 glucose transporter in rat skeletal muscle and in normal and hypoxic cardiac tissue. Am J Physiol 265: E454-E464, 1993. (Pubitemid 23296560)
9. Agus DB, Gambhir SS, Pardridge WM, Spielholz C, Baselga J, Vera JC and Golde DW: Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters. J Clin Invest 100: 2842-2848, 1997. (Pubitemid 28007554)
10. Haber SR, Weiser RK, Pritsker A, Reder I and Burstein ED: GLUT-1 glucose transporter expression in benign and malignant thyroid nodules. Thyroid 7: 363-367, 1997.
11. Younes M, Lechago LV and Lechago J: Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases. Clin Cancer Res 2: 1151-1154, 1996. (Pubitemid 26238445)
12. Ogawa J, Inoue H and Koide S: Glucose-transporter-typy-1-gene amplification correlates with sialyl-lewis-X synthesis and proliferation in lung cancer. Int J Cancer 74: 189-192, 1997. (Pubitemid 27234509)
13. Wang YB, Kalir T, Sabo E, Sherman ED, Cohen C and Burstein ED: Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia. Cancer 88: 2774-2781, 2000. (Pubitemid 30417938)
14. Schönberger J, Ruschoff J, Grimm D, Marienhagen J, Rümmele P, Meyringer R, Kossmehl P, Hofstsedter F and Eilles C: Glucose transporter 1 gene expression is related to thyroid neoplasms with an unfavorable prognosis: an immunohistochemical study. Thyroid 12: 747-754, 2002.
15. Lambert DW, Wood IS, Ellis A and Shirazi-Beechey SP: Molecular changes in the expression of human colonic nutrient transporters during the transition from normality to malignancy. Br J Cancer 86: 1262-1269, 2002.
16. Cooper R, Sarioglu S, Sokmen S, Fuzun M, Kupelioglu A, Valentine H, Gorken IB, Airley R and West C: Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma? Br J Cancer 89: 870-976, 2003.
17. Rudlowski C, Moser M, Becker AJ, Rath W, Buttner R, Schroder W and Schurmann A: GLUT1 mRNA and protein expression in ovarian borderline tumors and cancer. Oncology 66: 404-410, 2004. (Pubitemid 39194363)
18. Adler LP and Bloom AD: Positron emission tomography of thyroid masses. Thyroid 3: 195-200, 1993. (Pubitemid 23298921)
19. 99mTc-sestamibi scintygraphy in differentiated thyroid cancer. Thyroid 7: 327-335, 1997.
20. Wang W, Larson SM, Fazzari M, Tickoo SK, Kolbert K, Sgouros G, Yeung H, Macaplinlac H, Rossi J and Robbins RJ: Prognostic value of [18F] fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. J Clin Endocrinol Metab 85: 1107-1113, 2000. (Pubitemid 32269357)
21. Rose PG, Faulhaber P, Miraldi F and Abdul-Karim FW: Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy. Gynecol Oncol 82: 17-21, 2001. (Pubitemid 32634948)
22. Miyakita H, Tokunaga M, Onoda H, Usui Y, Kionoshita H, Kawamura N and Yasuda S: Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer. Int J Urol 9: 15-18, 2002. (Pubitemid 34309961)
23. Hiraki Y, Rosen OM and Birnbaum MJ: Growth factors rapidly induce expression of the glucose-transporter gene. J Bio Chem 263: 13655-13662, 1988.
24. Kamoshida S, Ogane N, Yasuda M, Muramatu T, Bessho T, Kajiwara H and Osamura RY: Immunohistochemical study of type-1 blood antigen expression in thyroid tumors: the significance for papillary carcinoma. Mod Pathol 13: 736-741, 2000. (Pubitemid 30470162)
25. Saxén E, Franssila KO, Bjarnason O, Normann T and Ringeryz N: Observer variation in histologic classification of thyroid cancer. Acta Pathol Microbiol Scand 86: 483-486, 1978. (Pubitemid 9053675)
26. Raphael SJ, McKeown-Eyssen G and Asa SL: High-molecular-weight cytokeratin and cytokeratin-19 in the diagnosis of thyroid tumors. Mod Pathol 7: 295-300, 1994.
27. Hirokawa M, Carney JA and Ohtsuki Y: Hyalinizing trabecular adenoma and papillary carcinoma of the thyroid gland express different cytokeratin patterns. Am J Surg Pathol 24: 877-881, 2000. (Pubitemid 30366277)
28. Liberman E and Weidner N: Papillary and follicular neoplasms of the thyroid gland. Differential immunohistochemical staining with higt-molecular-weight keratin and involucrin. Appl Irnmunohistochem Mol Morphol 8: 42-48, 2000. (Pubitemid 30152353)
29. Cohen CM and Gascard P: Regulation and post-translational modification of erythrocyte membrane and membrane-skeletal proteins. Semin Hematol 29: 244-292, 1992.